Ok since 2013 tis have had 3 cap raising and now still have to do another study to get considered for CE mark let alone do a trial for the FDA...
More raisings to come imo... Might look at TIS again when/if it's gets approval and sales actually start... Whenever that may be
surprised it's held up this well price wise
